Growth Metrics

Mitesco (MITI) Cash & Equivalents (2011 - 2026)

Mitesco (MITI) reported Cash & Equivalents of $1533.0 for Q1 2026, up 711.11% year-over-year from $189.0 in Q1 2025, and down 98.48% on a QoQ basis from $100857.0 in Q4 2025.

Mitesco (MITI) has 16 years of Cash & Equivalents data on file, last reported at $1533.0 in Q1 2026.

  • Quarterly Cash & Equivalents rose 711.11% year-over-year to $1533.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1533.0 (up 711.11% YoY) and the FY2025 annual result came in at $100857.0, up 2864.64% from the prior year.
  • Cash & Equivalents eased to $1533.0 in Q1 2026 per MITI's latest filing, from $100857.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $300000.0 in Q2 2023 and bottomed at $189.0 in Q1 2025.
  • The 5-year median for Cash & Equivalents is $24642.0 (2023), against an average of $52386.8.
  • The widest annual swing landed in 2023, when Cash & Equivalents sank 99.89%; it then soared 13540.47% in 2024.
  • Tracing MITI's Cash & Equivalents over 5 years: stood at $35623.0 in 2022, then plunged by 92.03% to $2838.0 in 2023, then grew by 19.87% to $3402.0 in 2024, then soared by 2864.64% to $100857.0 in 2025, then sank by 98.48% to $1533.0 in 2026.
  • Per Business Quant, the three latest MITI Cash & Equivalents figures stand at $1533.0 (Q1 2026), $100857.0 (Q4 2025), and $300.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 1.42 Bn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 888.80 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 265.37 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 186.67 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 219.18 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 34.34 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 490.29 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 419.52 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 174.90 Mn
10 Mitesco - - - 1,533.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,533.00
Dec 31, 2025 100,857.00
Sep 30, 2025 321.00
Jun 30, 2025 2,700.00
Mar 31, 2025 200.00
Dec 31, 2024 3,402.00
Sep 30, 2024 32,000.00
Jun 30, 2024 40,000.00
Mar 31, 2024 41,000.00
Dec 31, 2023 2,838.00
Sep 30, 2023 24,642.00
Jun 30, 2023 300,000.00
Mar 31, 2023 299.00
Dec 31, 2022 35,623.00
Sep 30, 2022 6,000.00
Jun 30, 2022 36,000.00
Mar 31, 2022 300,000.00
Dec 31, 2021 1.20 Mn
Sep 30, 2021 442,000.00
Jun 30, 2021 1.69 Mn
Mar 31, 2021 1.20 Mn
Dec 31, 2020 100,000.00
Sep 30, 2020 101,660.00
Jun 30, 2020 17,542.00
Mar 31, 2020 10,870.00
Dec 31, 2019 83,245.00
Sep 30, 2019 851.00
Jun 30, 2019 284.00
Mar 31, 2019 9,141.00
Dec 31, 2018 1,304.00
Sep 30, 2018 9,110.00
Jun 30, 2018 1,108.00
Sep 30, 2017 55.00
Jun 30, 2017 55.00
Mar 31, 2017 55.00
Jun 30, 2016 20,571.00
Mar 31, 2016 17,881.00
Dec 31, 2015 28,185.00
Sep 30, 2015 51,905.00
Jun 30, 2015 16,000.00
Mar 31, 2015 16,524.00
Dec 31, 2014 14,119.00
Sep 30, 2014 9,089.00
Jun 30, 2014 49,386.00
Mar 31, 2014 163,108.00
Dec 31, 2013 812,064.00
Sep 30, 2013 1.57 Mn
Jun 30, 2013 2.36 Mn
Mar 31, 2013 31,559.00
Dec 31, 2012 13,724.00
Sep 30, 2012 1,531.00
Jun 30, 2012 2,494.00
Mar 31, 2012 3,020.00
Dec 31, 2011 123,135.00
Sep 30, 2011 3,775.00
Mar 31, 2011 4,550.00